This can induce oxidation of methionine residues (M281/282) in the CaMKII regulatory subunit, leading to cardiomyocyte apoptosis, both in vitro and in vivo [115], atrial fibrillation [101], and diabetes-related bradycardia after myocardial infarction [102]. This evidence concerns the gene CAMK2G and myocardial infarction.